UPDATE 1-New buyout firm BayPine close to $6 bln Mavis Tire acquisition-sources
(Provides BayPine partnering with TSG Shopper Associates)By Greg Roumeliotis and Joshua FranklinMarch 2 (Reuters) - BayPine LP is in the...
(Provides BayPine partnering with TSG Shopper Associates)By Greg Roumeliotis and Joshua FranklinMarch 2 (Reuters) - BayPine LP is in the...
(Updates with hearing underway, lawmaker response)By David Shepardson and Tracy RucinskiWASHINGTON, March 2 (Reuters) - The head of a group...
TipRanksGoldman Sachs Predicts More than 50% Rally for These 2 SharesShares started off this calendar year with heft gains, edged...
TipRanksGoldman Sachs Predicts Around 50% Rally for These 2 StocksShares commenced this yr with heft gains, edged back previous week,...
Movie courtesy: Go Inexperienced LandscapingUPDATE (5:55pm): A witness fireplace tells 6 News the hearth transpired at a warehouse for Alpha...
- UPLIFT, a single-arm registration strategy evaluating upifitamab rilsodotin (UpRi) in platinum-resistant ovarian cancer, on track to begin in Q1...
VXA-CoV2-1 oral COVID-19 vaccine candidate targeting both the S and N proteins is planned to advance to Phase 2 testing...
Company demonstrates resilience despite COVID-19 challenges: Financial situation secure and development programs progressingConference call begins today at 4:30 p.m. (ET)BASKING...
– 2020 Highlights Include: Enrollment Completion of Pivotal PHYOX™2 Trial of Nedosiran for Primary Hyperoxaluria; Positive RG6346 Phase 1 Data...
2020 Net Revenues of $83.1 Million Increased 19% over 2019Fourth Quarter Net Revenues of $24.7 Million or $80 Per BottleNew...
(Updates with new headline)By Florence Tan and Gavin MaguireSINGAPORE, Feb 25 (Reuters) - Dow Inc is adjusting its carbon footprint...
– NDA and MAA for odevixibat accepted, on track for anticipated H2 21 launch –– Announces odevixibat co-promotion agreement with...
- Outlined strategy to build integrated cell therapy company and the Company’s “2-2-5-2” five-year core value drivers -- Reported compelling...
Two Phase 3 trials, EMERGENT-2 and EMERGENT-4, initiated evaluating KarXT for the treatment of psychosis in adults with schizophreniaResults from...
TipRanks2 Shares Buying and selling at Rock-Bottom Costs Analysts Say ‘Buy’We’re in a risky period proper now, as shares slipping...
TipRanks3 Stocks Goldman Sachs Suggests Are All set to Rip GreaterIs the bull market place about to choose a lengthy...
MCLEAN, VA / ACCESSWIRE / February 23, 2021 /Gladstone Commercial Corporation (NASDAQ:Good) ("we" or "Gladstone Industrial") is a true estate...
Combination with Thunder Bridge Acquisition II on Keep track of to Close Early Spring 2021Clears Hart-Scott-Rodino Transaction HurdleBusiness Sees Strengthening...